Ezer Flu&COVID-19 Antigen Combo Rapid Test
Introductio
Virus influenzae familiae pertinetOrthomyxoviridaeatque inmunologice diversae RNA virus subductis.Virus ibi influenza A et B principale pathogen est, quod graves morbos tam in hominibus quam in multis animalibus speciebus habent.Ex investigatione hodierna epidemiologica, incubatio periodus 1 ad 4 dies est.Manifestationes principales includunt febres acutas, dolores generales et symptomata respiratoria.Virus utrumque genus A et B eodem tempore versari possunt, sed plerumque unum genus in dato tempore dominatur.
COVID-19 morbus infectious respiratorii acutus.Populus fere suscipit.In statu, aegri novo coronaviro infecti praecipue sunt infectionis fons;asymptomatici homines infecti possunt etiam fons infectiosus esse.Ex hodierna investigatione epidemiologica, incubatio periodus 1 ad 14 dies est, plerumque 3 ad 7 dies.Praecipua manifestationes sunt febrem, lassitudinem et tussim aridam.Nasi congestio, liquescens nasus, faucium, myalgia et diarrhoea in paucis inveniuntur.
Signa et indicia clinica infectionis viralis respiratorii ob SARS-CoV-2 et influenza similia esse possunt.SARS-CoV-2, influenza A et influenza B antigenae virales plerumque deprehenduntur in speciminibus respiratoriis superioribus in acuta periodo contagionis.
EzerTMFlu&COVID-19 Antigen Combo Rapid Test includit influenza antigenum celeri experimentum et COVID-19 antigenum celeri experimentum, immunochromatographic examinatio pro qualitate detectionis 2019 Novella Coronavirus, influenza A et B antigens.EzerTMFlu&COVID-19 Antigen Combo Celeri Test has quattuor litteras in superficie clavi indicantes lineam test (S) ﹑ (A) ﹑ (B) et lineam (C).
Deprehensio
EzerTMFlu&COVID-19 Antigen Combo Celeri Test destinatur ad detectionem qualitativam simultaneam et differentiationem dapibus antigenis nucleocapsidis a SARS-CoV-2, influenza A et influenza B in speciminibus nasi directis.
Specimen
Nasal
Finis Deprehensio (LoD)
Flu&COVID-19 ：140 TCID50/mL
Deprehensio minimum terminum Flu A pro EzerTMFlu&COVID-19 Antigen Combo Celeri Test fundatum est in summa 8 influenza A.
| Influenza Viral Strain | Ratione LoD |
| A/Nova Caledonia/20/1999_H1N1 | 8.50x103 |
| A/California/04/2009_H1N1 | 2.11x103 |
| A/PR/8/34_H1N1 | 2.93x103 |
| A/Bean Goose/Hubei/chenhu XVI35-1/2016_H3N2 | 4.94x102 |
| A/Guizhou/54/89_H3N2 | 3.95x102 |
| A/Humanum/Hubei/3/2005_H3N2 | 2.93x104 |
| A/Bar-headed Goose/QH/BTY2/2015_H5N1 | 1.98x105 |
| A/Anhui/1/2013_H7N9 | 7.90x105 |
Flu B minimum deprehendendi modum pro EzerTMFlu&COVID-19 Antigen Combo Celeri Test fundatum est in summa 2 influenza B.
| Influenza Viral Strain | Ratione LoD |
| B/Victoria | 4.25x103 |
| B/Yamagata | 1.58x102 |
Sagaciter
|
| Influenza A | Influenza B | COVID-19 |
| Relativum Sensitivum | 86.8% | 91.7% | 96.6% |
| Relativum Specification | 94.0% | 97.5% | 100% |
| Sagaciter | 92.2% | 96.1% | 98.9% |
Tempus proventuum
Proventus legit in 15minutis et non plus quam 30 minuta.
Ornamentum repono conditionibus
2~30°C
Contents
| Descriptio | Qty |
| Test machinas | 20 |
| Venenatis swabs | 20 |
| Extraction tube | 20 |
| Nozzles | 20 |
| Tubus sto | 1 |
| sarcina inserta | 1 |
Informationes iussis
| Productum | Cat.No. | Contents |
| EzerTMFlu&COVID-19 Antigen Combo | P213110 | 20 Test |
